Emerging strategies for exploiting cannabinoid receptor agonists as medicines.
Subject: General - PUBLISHED VIA British Journal of Pharmacology
Author(s):
Pertwee RG
View Source >>
Related Studies:
Safety and side effects of cannabidiol, a Cannabis sativa constituent.
Published via Bentham Science Publishers
Cannabidiol: an overview of some pharmacological aspects.
Published via The Journal of Clinical Pharmacology
Cannabinoids in clinical practice.
Published via Adis International Limited
Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
Published via Neuropsychopharmacology
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb.
Published via Cell Press
Understanding the molecular aspects of tetrahydrocannabinol and cannabidiol as antioxidants.
Published via Molecules
Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system.
Published via PLOS ONE
Pharmacology of Cannabinoids
Published via Neuroendocrinology Letters
Advances in Experimental Medicine and Biology
Published via Philosophical Transactions of the Royal Society B
The endocannabinoid system as an emerging target of pharmacotherapy.
Published via Pharmacological Reviews
The therapeutic potential of cannabis and cannabinoids.
Published via Deutsches Ärzteblatt Int
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action.
Published via Revista Brasileira de Psiquiatria
Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects.
Published via Chemistry and Physics of Lipids
Therapeutic potential of cannabinoid-based drugs.
Published via Advances in Experimental Medicine and Biology
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.
Published via Free Radical Biology and Medicine
Combined cannabinoid therapy via an oromucosal spray.
Published via Drugs Today
A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol
Published via Medical Hypotheses